Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

Phase 1/2 Completed 11 enrolled Dana-Farber Cancer Institute Stand Up To Cancer · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This research study is studying a therapeutic vaccine, named DPX-E7, as a possible treatment for Human Papilloma Virus or HPV related head and neck, cervical or anal cancer (positive for HLA-A\*02).

Timeline

Start: 2017-03-30
Primary completion: 2019-10-04
Completion: 2023-02-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cyclophosphamide	Other / unclassified	50 mg	Oral
Subject	DPX-E7	Unknown	0.1 ml	—
Subject	DPX-E7	Unknown	0.2 ml	—

Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

Summary

Timeline

Drugs

Indications